CPA
ARKG icon

Cardiff Park Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cardiff Park Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,207
Closed -$41.2K – 309
2023
Q2 		$41.2K Hold
1,207
– – 0.01% 287
2023
Q1 		$36.3K Buy
+1,207
New +$37.4K ﹤0.01% 282

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Cardiff Park Advisors's ARKG Position: Q3 2023 in Review

Cardiff Park Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 1,207 shares — an estimated $41.2K sold.

Cardiff Park Advisors first reported a position in ARKG in Q1 2023 and held it in 2 quarters. The position peaked at $41.2K in Q2 2023. 286 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

  • Cardiff Park Advisors reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
  • Cardiff Park Advisors sold 1,207 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $41.2K.
  • Cardiff Park Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 2 quarters.
  • Cardiff Park Advisors's ARK Genomic Revolution ETF position peaked at $41.2K in Q2 2023.
  • 286 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Cardiff Park Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.